Your session is about to expire
← Back to Search
The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis
N/A
Recruiting
Research Sponsored by University of Regina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
between the ages of 8 and 12
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to test if an online mental health program can help improve the mental health and quality of life for healthy children and adolescents who have siblings with cystic fibrosis (CF). The trial also
Who is the study for?
This trial is for healthy children and adolescents aged 8 to 12 who have a sibling with cystic fibrosis. Participants must be able to speak and read English.
What is being tested?
The trial tests an online mental health program (iCF-PWR) designed for siblings of individuals with CF, aiming to improve their mental health, quality of life, sibling relationships, and knowledge about CF.
What are the potential side effects?
Since this is a non-medical intervention focusing on mental health through an internet-based program, there are no direct physical side effects expected from participation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 8 and 12 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from Baseline in the Childhood Anxiety Sensitivity Index (CASI)
Change from Baseline in the Childhood Illness Attitudes Scale (CIAS)
Change from Baseline in the Children's Depression Inventory-2 (CDI-2)
+6 moreSecondary study objectives
Change from Baseline in the Children's Depression Inventory-2 - Parent Report (CDI-2 P)
Change from Baseline in the State-Trait Anxiety Inventory - Parent Version (STAI-P)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: iCF-PWR InterventionExperimental Treatment1 Intervention
Internet-delivered Cystic Fibrosis Mental Health Prevention, Wellness, and Resource (iCF-PWR) program is comprised of five text/voice-delivered, animated, interactive modules. The pathways are comprised of the same modules that take approximately 15 to 20 minutes to complete. Modules are comprised of web pages and/or screens with numerous illustrations and interactive components. Written module content will be presented verbally as well as in text format.
The program modules include: (1) What is CF? (i.e., physiological explanation of CF, prevalence rate); (2) How does my sibling with CF stay healthy? (i.e., review of medication, nutrition, physiotherapy treatment, and why treatment is important); (3) How does CF affect me?; (4) Mental health awareness (i.e., introduction to cognitive behaviour model of emotions-thoughts, feelings, bodily sensations, and behaviours); and (5) Strategies (i.e., ways to challenge unhelpful thoughts, talking about emotions, relaxation).
Find a Location
Who is running the clinical trial?
Saskatchewan Health Authority - Regina AreaOTHER
28 Previous Clinical Trials
5,427 Total Patients Enrolled
1 Trials studying Cystic Fibrosis
120 Patients Enrolled for Cystic Fibrosis
University of ReginaLead Sponsor
56 Previous Clinical Trials
8,986 Total Patients Enrolled
2 Trials studying Cystic Fibrosis
147 Patients Enrolled for Cystic Fibrosis
Provincial Health Services AuthorityOTHER
39 Previous Clinical Trials
31,850 Total Patients Enrolled
1 Trials studying Cystic Fibrosis
120 Patients Enrolled for Cystic Fibrosis
Kristi D Wright, Ph.DStudy DirectorUniversity of Regina